Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/22/2001 | DE10020996A1 Isoprenoidbiosynthese Isoprenoid biosynthesis |
03/22/2001 | CA2388419A1 Cacna1g polynucleotide, polypeptide and methods of use therefor |
03/22/2001 | CA2388364A1 Plants having reduced activity in two or more starch-modifying enzymes |
03/22/2001 | CA2388072A1 Transcriptionally silenced plant genes |
03/22/2001 | CA2386559A1 Isolation of muscle-derived stem cells and uses therefor |
03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
03/22/2001 | CA2385241A1 Micro-organisms, their use and method for producing d-amino acids |
03/22/2001 | CA2385234A1 Nrage nucleic acids and polypeptides and uses thereof |
03/22/2001 | CA2384987A1 Nucleic acids encoding polyepitope polypeptides |
03/22/2001 | CA2384967A1 Lepidopteran-active bacillus thuringiensis .delta.-endotoxin compositions and methods of use |
03/22/2001 | CA2384920A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
03/22/2001 | CA2384916A1 Plants having altered amino acid contents and method for the production thereof |
03/22/2001 | CA2384860A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
03/22/2001 | CA2384855A1 Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
03/22/2001 | CA2384766A1 Subunit optimized fusion proteins |
03/22/2001 | CA2384762A1 Apo-2 receptor antibodies |
03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
03/22/2001 | CA2384660A1 Factor ix/factor ixa antibodies and antibody derivatives |
03/22/2001 | CA2384637A1 Nucleotide sequences derived from genes coding for trimethylamine n-oxide reductase, uses thereof in particular for detecting bacteria |
03/22/2001 | CA2384445A1 Methods and compositions for the screening of cell cycle modulators |
03/22/2001 | CA2384439A1 Modified adenoviral vectors for use in gene therapy |
03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
03/22/2001 | CA2384135A1 Dipeptidyl peptidases |
03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
03/22/2001 | CA2383423A1 Reverse transfection method |
03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
03/22/2001 | CA2383292A1 Basb128 polypeptide and polynucleotide from moxarella catarrhalis |
03/22/2001 | CA2383217A1 Lysosomal targeting pathway enzymes |
03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
03/22/2001 | CA2383081A1 Polypeptides from moraxella (branhamella) catarrhalis |
03/22/2001 | CA2383003A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
03/22/2001 | CA2382444A1 Dna construct and its use |
03/22/2001 | CA2382067A1 Recombinant microorganisms |
03/22/2001 | CA2381347A1 Regulatory sequences and expression cassettes for yeasts |
03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
03/22/2001 | CA2380383A1 Genetic markers of toxicity, preparation and uses thereof |
03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
03/22/2001 | CA2375746A1 Improved column for dna separation by matched ion polynucleotide chromatography |
03/22/2001 | CA2350823A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
03/21/2001 | EP1085468A2 Graphical viewer for biomolecular sequence data |
03/21/2001 | EP1085323A2 NADE binding proteins |
03/21/2001 | EP1085102A2 A method for reverse transcribing RNA isolated in dry form |
03/21/2001 | EP1085098A2 A composition for providing long term stability to cells for diagnostic testing |
03/21/2001 | EP1085094A2 Nucleotide sequences which code for the dapF gene |
03/21/2001 | EP1085093A2 Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof |
03/21/2001 | EP1085092A1 Phosphodiesterase enzymes |
03/21/2001 | EP1085091A1 Nucleotide sequences coding for thrE-gene and process for the fermentative preparation of L-threonine using coryneform bacteria |
03/21/2001 | EP1085090A1 IgA NEPHROPATHY-ASSOCIATED DNA |
03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
03/21/2001 | EP1085088A1 Monoclonal antibodies and method for assaying fdp |
03/21/2001 | EP1085087A2 Method for producing amino acids by fermentation using aminoquinoline resistant bacterial strains |
03/21/2001 | EP1085086A2 Method for producing amino acids by fermentation using DNA gyrase inhibitor resistant bacterial strains |
03/21/2001 | EP1085024A1 Peptides having nuclear transport activity |
03/21/2001 | EP1084748A2 Membrane-shaped biopolymer adsorbing material and biopolymer adsorbing kit |
03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
03/21/2001 | EP1084277A2 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components |
03/21/2001 | EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
03/21/2001 | EP1084273A1 Probes used for genetic profiling |
03/21/2001 | EP1084272A1 Heteroduplex mutational vectors and use thereof in bacteria |
03/21/2001 | EP1084267A1 Vitamin c production in microorganisms and plants |
03/21/2001 | EP1084263A1 Hematopoietic progenitor cell gene transduction |
03/21/2001 | EP1084262A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
03/21/2001 | EP1084261A1 Recombinant venezuelan equine encephalitis virus vaccine |
03/21/2001 | EP1084260A2 Caspase-9 deficient animals and the use thereof |
03/21/2001 | EP1084259A1 Corin, a serine protease |
03/21/2001 | EP1084258A1 Industrial method for producing heterologous proteins in e.coli and strains useful for said method |
03/21/2001 | EP1084257A1 A STRAIN E.COLI JM83/pKP2 TRANSFORMED WITH A NOVEL PLASMID AND PHYTASE PRODUCED THEREFROM |
03/21/2001 | EP1084256A2 Acyl coa:cholesterol acyltransferase related nucleic acid sequences |
03/21/2001 | EP1084255A1 Tankyrase, a trf1 binding protein |
03/21/2001 | EP1084254A1 Transgenic plants presenting a modified inulin producing profile |
03/21/2001 | EP1084253A1 Hiv virus mimotopes |
03/21/2001 | EP1084252A1 Nucleic acid vaccines for prevention of flavivirus infection |
03/21/2001 | EP1084251A2 Attenuated pestiviruses |
03/21/2001 | EP1084250A2 Enzyme |
03/21/2001 | EP1084249A2 Transgenic plant cells expressing a recombinant plant e2f peptide |
03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
03/21/2001 | EP1084247A1 Disulfide core polypeptides |
03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
03/21/2001 | EP1084245A1 Human receptor tyrosine kinase |
03/21/2001 | EP1084244A1 Tnfr-like protein with death domain |
03/21/2001 | EP1084243A2 Protein for regulating apoptosis |
03/21/2001 | EP1084242A2 Phagocytic assay method |
03/21/2001 | EP1084241A1 G-protein coupled receptor, named 2871 receptor |
03/21/2001 | EP1084240A1 Polypeptides with beta-secretase type activity |
03/21/2001 | EP1084239A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
03/21/2001 | EP1084238A1 Dna encoding orphan receptors |
03/21/2001 | EP1084237A1 Stabilized transient gene expression |
03/21/2001 | EP1084236A1 Novel adenoviral vectors for gene therapy |
03/21/2001 | EP1084235A1 Human protein c polypeptide |
03/21/2001 | EP1084234A2 Human deadenylating nuclease, its production and its use |
03/21/2001 | EP1084233A1 Packaging kit |
03/21/2001 | EP1084232A1 Genetically-modified fibroblasts and the use thereof |
03/21/2001 | EP1084231A1 Transformed cell lines which express heterologous g-protein-coupled receptors |
03/21/2001 | EP1084228A1 GENES CODING FOR TOMATO beta-GALACTOSIDASE POLYPEPTIDES |
03/21/2001 | EP1084227A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |